We are live on
!
Find out more
TRCT
Tower Research Capital (TRC) Portfolio holdings
AUM
$3.85B
1-Year Est. Return
32.11%
This Fund
S&P 500
This Quarter
Est. Return
+26.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$2.44B
AUM Growth
+$792M
(+48%)
Cap. Flow
+$442M
Cap. Flow
% of AUM
18.15%
Top 10 Holdings %
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$55.3M |
| 2 |
Apple
AAPL
|
+$33.2M |
| 3 |
Amazon
AMZN
|
+$29.2M |
| 4 |
Microsoft
MSFT
|
+$26.4M |
| 5 |
Direxion Daily Semiconductor Bull 3X ETF
SOXL
|
+$22.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$342M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$93.3M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$86M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$51.5M |
| 5 |
State Street Utilities Select Sector SPDR ETF
XLU
|
+$29.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.14% |
| 2 | Healthcare | 9.57% |
| 3 | Financials | 8.79% |
| 4 | Industrials | 7.76% |
| 5 | Consumer Discretionary | 7.68% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4001
Cellectar Biosciences
CLRB
$20.8M
| $10K | ﹤0.01% |
+26
| New | +$10.9K |
|
4002
CNA Financial
CNA
$13.9B
| $10K | ﹤0.01% |
296
-2,907
| -91% | -$89.5K |
|
4003
Choiceone Financial
COFS
$508M
| $10K | ﹤0.01% |
+341
| New | +$9.68K |
|
4004
Civeo
CVEO
$330M
| $10K | ﹤0.01% |
1,412
-163
| -10% | -$1K |
|
4005
Fennec Pharmaceuticals
FENC
$380M
| $10K | ﹤0.01% |
+1,176
| New | +$8.75K |
|
4006
First Trust Switzerland AlphaDEX Fund
FSZ
$37.3M
| $10K | ﹤0.01% |
+200
| New | +$9.17K |
|
4007
GrowGeneration
GRWG
$85.9M
| $10K | ﹤0.01% |
+1,427
| New | +$7.85K |
|
4008
GSK
GSK
$104B
| $10K | ﹤0.01% |
189
-10,098
| -98% | -$518K |
|
4009
HireQuest
HQI
$189M
| $10K | ﹤0.01% |
+1,636
| New | +$10.3K |
|
|
ICAD
4010
DELISTED
iCAD Inc
ICAD
| $10K | ﹤0.01% |
1,004
+305
| +44% | +$3.29K |
|
4011
InflaRx
IFRX
$289M
| $10K | ﹤0.01% |
2,076
+1,813
| +689% | +$11.8K |
|
4012
Invesco AI and Next Gen Software ETF
IGPT
$1.14B
| $10K | ﹤0.01% |
261
-82,209
| -100% | -$2.82M |
|
4013
InfuSystem Holdings
INFU
$241M
| $10K | ﹤0.01% |
852
+457
| +116% | +$5.25K |
|
4014
InterGroup Corp
INTG
$68.8M
| $10K | ﹤0.01% |
383
+146
| +62% | +$4.12K |
|
4015
PennantPark Floating Rate Capital
PFLT
$734M
| $10K | ﹤0.01% |
1,210
-8,005
| -87% | -$58.7K |
|
4016
Phunware
PHUN
$41.7M
| $10K | ﹤0.01% |
160
+140
| +700% | +$6.68K |
|
|
IMVP
4017
Invesco India ETF
IMVP
$108M
| $10K | ﹤0.01% |
580
+534
| +1,161% | +$8.38K |
|
4018
Nuveen NASDAQ 100 Dynamic Overwrite Fund
QQQX
$1.5B
| $10K | ﹤0.01% |
+424
| New | +$9.44K |
|
4019
Cartesian Therapeutics
RNAC
$265M
| $10K | ﹤0.01% |
+112
| New | +$10.2K |
|
4020
Super League Enterprise
SLE
$4.89M
| – | – |
0
| – | – |
|
|
STR
4021
DELISTED
Sitio Royalties
STR
| $10K | ﹤0.01% |
+770
| New | +$8.09K |
|
4022
Vivani Medical
VANI
$122M
| $10K | ﹤0.01% |
3,242
+2,057
| +174% | +$7.31K |
|
4023
Exagen
XGN
$161M
| $10K | ﹤0.01% |
+798
| New | +$10.8K |
|
|
ZEPP
4024
Zepp Health
ZEPP
$76.1M
| $10K | ﹤0.01% |
201
-755
| -79% | -$34.8K |
|
|
AIOT
4025
PowerFleet Inc
AIOT
$411M
| $10K | ﹤0.01% |
2,158
+1,148
| +114% | +$5.34K |
|
Similar funds
HFCIX
DWM
TFM
AC
IP
TCIM
FLSM
AFI
Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review
As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.
- Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
- Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
- Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
- Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
- Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
- Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
- Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.
Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.